5ZT-25030-83363
3 vaccinations
0 coded responses
10 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2022-10-01
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-04
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-02
Dose 2 — Moderna
-
2022-09-26
Dose 3 — Moderna
-
2022-10-01
Registered in v-safe
-
2022-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2022-10-02
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-11-01
- 2022-11-07
- 2022-12-26
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-04 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-02 | Moderna | No |
| 3 | 2022-09-26 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.